How double stabbed PIERS MORGAN caught Covid in the chaos of Wembley

How doubly-pricked PIERS MORGAN caught Covid in Wembley chaos: Star reveals his week of woes in Mail On Sunday after virus checks collapsed during European Championship final

  • Piers, 56, said he believes he caught the Delta Covid variant in the final
  • He is tormented by fever, cold sweat, cough, sneeze and pain
  • Piers said: ‘This is definitely the hardest I’ve felt from an illness in my adult life’

Piers Morgan has revealed that he has contracted Covid. during the crowd chaos that marred the Wembley European Championship final – despite being double stabbed.

In a powerful report for tomorrow’s Mail on Sunday, the 56-year-old broadcaster – one of the strongest critics of the government’s pandemic policy – describes how the virus caused raging fevers, chills and violent coughs and sneezes before he was exhausted and exhausted. stayed behind. afraid of what might come.

His report shows that he believed he contracted the Indian – or Delta – variant of the virus when he saw England’s defeat to Italy two weeks ago, despite official assurances that only fully vaccinated spectators, or those with negative tests, would be able to stadium would be allowed.

Piers, 56, with sons Stanley, Albert and Spencer at the Euro 2020 final at Wembley

“My confidence that the event would be ‘covid safe’ had fallen apart,” he recalls, noting the masses of ticketless yobs breaking through security.

“It turned into an unregulated free-for-all.”

Two days after the race he began to feel unwell at his village house in Sussex and did a lateral flow test.

Fans flock outside for Italy v England at Wembley Stadium in London for kick-off

Fans flock outside for Italy v England at Wembley Stadium in London for kick-off

Harry Maguire after defeat in the penalty shoot-out after the UEFA Euro 2020 Final

Harry Maguire after defeat in the penalty shoot-out after the UEFA Euro 2020 Final

How effective is the Oxford-AstraZeneca Covid vaccine?


Approved: December 30, 2020

Data from Phase 3 Trials

  • Efficacy in blocking symptoms (one dose): 70%
  • Efficacy against severe disease (one dose): 100%

Real world data:

  • Efficacy in stopping transmission: 70%
  • Efficacy in blocking symptoms: Between 60 and 73%
  • Efficacy against serious illness: 80%

How it works: adenovirus vaccine – To make the vaccine, the common cold virus is genetically modified to activate it to make the Covid spike protein – which the virus uses to invade cells.

When the vaccine is administered, the patient’s immune system attacks the spike protein by building up antibodies, preparing it to fight Covid before it leads to an infection.

When it came back positive, he did a final PCR test that confirmed the result four days after his trip to Wembley.

“As I’m sure everyone who gets it feels, it’s a strange, disturbing moment to know I have this deadly virus inside me,” he wrote in tomorrow’s Mail on Sunday.

Double poked with the Oxford AstraZeneca vaccine, the former Good Morning Britain presenter spoke to a respiratory expert who told him that no current vaccine completely protects against infection with some of the new variants, but crucially, they all offer strong protection. against hospitalization or death.

Piers describes how his body was ravaged by fever, cold sweats, coughing, sneezing and “strange pains” – and at one point “alarming” chest pain.

He adds, “And my voice now sounds like Barry White, though I didn’t feel any less of a Walrus of Love.”

His symptoms have now faded, but his forced incarceration gave him time to think about the pandemic.

This is definitely the heaviest I’ve felt from an illness in my adult life BUT, as I slowly come out the other side coughing and sputtering.

“I am still here – unlike so many millions around the world who have lost their lives to Covid in this pandemic,” he writes.

“For that, I am deeply indebted to the brilliant scientists at Oxford who have created the Astra-Zeneca vaccine at such an astonishing speed.”

For the full, dramatic story of Piers, don’t miss tomorrow’s Mail on Sunday…